cycrimine cycrimine cycrimine (trade name pagitane) is a central anticholinergic drug designed to reduce the levels of acetylcholine in the treatment of parkinson's disease. its mechanism of action is to bind to the muscarinic acetylcholine receptor m1. cycrimineclinical datalicense data us fda: cycrimine atc codenoneidentifiers iupac name 1-cyclopentyl-1-phenyl-3-(piperidin-1-yl)propan-1-ol cas number77-39-4pubchem cid2911drugbankdb00942chemspider2808unii543567rfqqchebichebi:59692 ychemblchembl1201227echa infocard100.000.932 chemical and physical dataformulac19h29nomolar mass287.447 g·mol−13d model (jsmol)interactive image smiles oc(ccn1ccccc1)(c2cccc2)c3ccccc3 inchi inchi=1s/c19h29no/c21-19(18-11-5-6-12-18,17-9-3-1-4-10-17)13-16-20-14-7-2-8-15-20/h1,3-4,9-10,18,21h,2,5-8,11-16h2key:swruzbwlewhwri-uhfffaoysa-n synthesis cycrimine synthesis: